<DOC>
	<DOCNO>NCT00954356</DOCNO>
	<brief_summary>The purpose trial determine XPF-001 effective treatment pain follow third-molar/wisdom tooth extraction .</brief_summary>
	<brief_title>Safety Efficacy Study XPF-001 Treat Pain Following Wisdom Tooth Extraction</brief_title>
	<detailed_description />
	<mesh_term>Toothache</mesh_term>
	<criteria>Males ( aged 1860 ) females nonchildbearing potential ( aged 1860 ; BMI 19.5 32.0 kg/m2 ; Outpatient , schedule undergo surgical extraction 2 impact 3rd molar ( least 1 partial bony mandibular extraction ) ; use follow preoperative medication 2 % lidocaine epinephrine nitrous oxide ; Able complete request information analgesic questionnaires able comply study procedure restriction ; Able read , comprehend sign consent form ; Deemed medically healthy participate study , normal clinically insignificant medical history , physical examination , lab test ECG result ; No contraindication study drug , excipients study medication include rescue medication . Presence clinically significant medical condition ; Positive test HIV , Hepatitis B Hepatitis C ; Use prescription counter medication supplement 48 hour dose study drug discharge ; Acute local infection time dental surgery ; Females pregnant , lactate childbearing potential , provide positive pregnancy test result screen checkin ; Males undertake adequate measure prevent partner become pregnant throughout study ; Clinically significant laboratory value ; Clinically significant abnormal ECG ; History presence alcoholism , alcohol substance abuse ( within previous 2 year ) , routine consumption 3 alcoholic drink per day ; A positive urine drug test ; Routine use analgesic 5 time per week ; Presence history ( within 2 year enrolment ) bleed disorder ( ) peptic ulcer disease ; History allergic reaction drug , include penicillin ; Ingestion caffeine contain food drink 24 hour dose study drug ; Consumption alcohol 48 hour dose study drug , positive alcohol breath test checkin ; Consumption grapefruit grapefruit contain product 7 day dose study drug ; Use tobacco nicotine substitute within 1 month dose study drug , inability refrain use nicotine checkin follow ; Treatment depression 6 month prior enrolment ; Use another investigational drug 60 day enrolment ; Donation loss 50500 mL blood 30 day prior enrolment , 500 mL blood 56 day enrolment ; Previously enter study ; Study site Sponsor employee relatives employee directly involve study ; Any condition ( opinion Investigator sponsor ) make subject unsuitable study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Pain follow 3rd molar/wisdom tooth extraction</keyword>
</DOC>